Urinary potassium and association with methotrexate (MTX) elimination delay in patients with primary central nervous system lymphoma (PCNSL). This is an ASCO Meeting Abstract from the 2022 ASCO Annual ...

All patients with PS II NSGCT seen at Memorial Sloan Kettering Cancer Center from March 1989 to April 2016 and who were planned to receive EP×2 were included. Each cycle consisted of cisplatin 20 mg/m ...

Cisplatin is one of the most widely used agents in the treatment of solid tumors, but its clinical utility is limited by toxicity. The development of less toxic, liposomal formulations of cisplatin ...

Please provide your email address to receive an email when new articles are posted on . Survival outcomes did not differ for patients with HNSCC who received radiotherapy with carboplatin-paclitaxel ...

Cisplatin-based chemotherapy regimens provide a survival benefit for patients with advanced or metastatic urothelial carcinoma of the bladder. Clinicians should follow established criteria for ...

Please provide your email address to receive an email when new articles are posted on . Only about 7% of patients with cancer in the United States may benefit from genome-driven care. A novel model ...

Credit: Getty Images. Pedmark is the first FDA-approved therapy indicated to reduce the risk of cisplatin-induced hearing loss in children. Pedmark ® (sodium thiosulfate) is now available to reduce ...

Cisplatin-based concurrent chemoradiation is the standard of care for patients with locoregionally advanced head and neck squamous cell carcinoma (HNSCC). The superiority of this therapeutic approach ...

An ongoing shortage of cancer drug cisplatin just got longer. Drugmakers told the American Society of Health-System Pharmacists they expect their cisplatin supply to return to normal levels in June, ...

A platinum-based chemotherapy drug, cisplatin is used to treat a variety of different cancer types including; carcinomas, lymphomas and sarcomas. 1 Although it was first synthesized in 1844 by the ...